Anti-HIV Agents
Showing 1 - 25 of >10,000
The Lymphoid Tissue Pharmacology of Antiretroviral Drugs
Not yet recruiting
- HIV Infection
- Anti-HIV Agents
- (no location specified)
Nov 4, 2022
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Active, not recruiting
- Human Immunodeficiency Virus
- +6 more
- Anti-HIV Agents
-
Lusaka, ZambiaCentre for Infectious Disease Research in Zambia (CIDRZ)
Jun 1, 2022
HIV Trial in United States (Abacavir sulfate, Lamivudine, Stavudine)
Completed
- HIV Infections
- Abacavir sulfate
- +4 more
-
Los Angeles, California
- +6 more
Oct 27, 2021
HIV Trial in United States (Pravastatin sodium, Simvastatin, Atorvastatin calcium)
Completed
- HIV Infections
- Pravastatin sodium
- +5 more
-
Los Angeles, California
- +12 more
Oct 27, 2021
Stroke, Medication Adherence Trial in Kumasi (Polycap)
Not yet recruiting
- Stroke
- Medication Adherence
-
Kumasi, GhanaKwame Nkrumah Institute of Science & Technology
Jul 19, 2023
Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)
Not yet recruiting
- HIV Seropositivity
- +2 more
- HIV Ag +Ab Assay Kit (Sysmex)
- (no location specified)
Aug 1, 2023
HIV Trial in Atlanta (Single dose of Genvoya® and a single 800 mg dose of Darunavir®)
Completed
- HIV Infections
- Single dose of Genvoya® and a single 800 mg dose of Darunavir®
-
Atlanta, GeorgiaEmory University
Aug 26, 2020
Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- INE963
- +3 more
- (no location specified)
Feb 17, 2023
Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and
Not yet recruiting
- Disability or Chronic Disease Leading to Disablement
- +2 more
- Surgical flap and anti-bacterial agents
-
Garches, FranceDepartment of Physical Medicine and Rehabilitation, Raymond Poin
Feb 1, 2023
Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)
Not yet recruiting
- Relapsed/Refractory Non-Hodgkin Lymphoma
-
Duarte, California
- +1 more
Oct 13, 2023
Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)
Recruiting
- Solid Tumor
-
Chuo-ku, Tokyo, JapanNational Cancer Center Hospital
Jun 14, 2023
Atherosclerosis, Adherence, Medication, Tolerance Trial in Kumasi (Polycap)
Completed
- Atherosclerosis
- +2 more
-
Kumasi, GhanaKwame Nkrumah University of Science & Technology
Sep 29, 2022
Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)
Completed
- Crohn's Disease
- Ulcerative Colitis
- Immuno monitoring
-
Montpellier, FranceUniversity hospital
Dec 13, 2022
IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)
Not yet recruiting
- Inflammatory Bowel Diseases
- Biological Substance; Adverse Effect
- Azithromycin Pill
- Placebo
-
Haifa, IsraelRambam Health Care Campus
Oct 25, 2022
Pneumonia, Pneumocystis Carinii, HIV Trial in Tanzania, United States (Pentamidine isethionate, Sulfamethoxazole-Trimethoprim,
Completed
- Pneumonia, Pneumocystis Carinii
- HIV Infections
- Pentamidine isethionate
- +3 more
-
Los Angeles, California
- +20 more
Oct 28, 2021
Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Canakinumab
- Placebo
-
Charlestown, Massachusetts
- +11 more
Nov 11, 2022
Tumors Trial run by the NCI (Nilotinib and Paclitaxel)
Recruiting
- Neoplasms
- Nilotinib and Paclitaxel
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Early Anti-Retroviral Treatment in HIV- Infected Children
Active, not recruiting
- HIV Infections
- Blood samples collection
-
Bamako, Mali
- +5 more
Mar 13, 2023
Risk of NSAIDs on Anastomotic Leak for Rectal Surgery
Recruiting
- Anastomotic Leak
- Anti-Inflammatory Agents, Non-Steroidal
-
Chongqing, None Selected, ChinaArmy Medical Center
Nov 24, 2023